NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

M. H. Frick, Olli Elo, Kauko Haapa et al. · New England Journal of Medicine · 1987 · 3.9K citations

Medicine, Cardiology, Pharmacotherapy +17

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Hanna E. Bloomfield, Sander J. Robins, Dorothea Collins et al. · New England Journal of Medicine · 1999 · 3.5K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

David J. Gordon, Jeffrey L. Probstfield, Robert J. Garrison et al. · Circulation · 1989 · 3.2K citations · Full text

Medicine, Cardiology, Preventive Medicine +17

Effects of Torcetrapib in Patients at High Risk for Coronary Events

Philip J. Barter, Mark J. Caulfield, Mats Eriksson et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text

Medicine, Cardiology, Pharmacology +14

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

Gregory G. Schwartz, Anders Olsson, Markus Abt et al. · New England Journal of Medicine · 2012 · 2K citations · Full text

Medicine, Cardiology, Pharmacology +17